X

Trial Profile

A human abuse potential study of Rexista

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 17 Oct 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Oxycodone (Primary)
Indications Pain
Focus Therapeutic Use

Most Recent Events

10 Oct 2018 According to an Intellipharmaceutics International clinical component of study has been completed.Bioanalytical samples and statistical analysis for such studies are pending. An update on the results will be provided once the analysis is complete.
08 May 2018 Status changed from planning to recruiting, according to an Intellipharmaceutics media release.
08 May 2018 According to an Intellipharmaceutics media release, this study is being conducted by the Altasciences Clinical Research (Montreal).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com